Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. HeartWare launches European trial for next-gen MVAD heart pump
HeartWare International said that it’s launching a clinical trial aimed at winning CE Mark approval in the European Union for its next-generation MVAD implantable heart pump.
The prospective, non-randomized, single-arm study is slated to enroll 60 patients, who will be implanted with the MVAD pump via sternotomy or thoracotomy, with a primary endpoint of survival at 6 months, HeartWare said. Read more
2. GE Healthcare’s Q2 sales, profits decline
Both the top and bottom lines declined about -3% for GE Healthcare during the 2nd quarter, General Electric reported.
GE Healthcare posted profits of $705 million on $4.34 billion in sales for the 3 months ended June 30, down -3.3% and -3.4%, respectively. Read more
1. Stryker pulls the trigger on Muka Metal acquisition
Stryker confirmed an earlier report of the acquisition of Turkish hospital bed and stretcher maker Muka Metal in an all-cash transaction, but did not specify the amount.
Kayseri, Turkey-based Muka began producing hospital beds in 2004, and has expanded into patient handling equipment, stretchers and hospital furniture. The company, founded in 1966, developed the 1st wireless nurse calling system, and exports to 60 countries across the U.S. It also makes non-medical products, including office furniture and household electrical appliances. Read more
The post MassDevice.com +3 | The top 3 medtech stories for July 20, 2015 appeared first on MassDevice.
from MassDevice http://ift.tt/1HM3Sbi
Cap comentari:
Publica un comentari a l'entrada